Literature DB >> 7890395

Prolonged expression of lipopolysaccharide (LPS)-induced inflammatory genes in whole blood requires continual exposure to LPS.

R L Dedrick1, P J Conlon.   

Abstract

Blood-borne lipopolysaccharide (LPS) is thought to be a major inducer of sepsis; however, it remains controversial whether an ongoing exposure to LPS is required to maintain the underlying systemic inflammatory response. To address this question, we have studied the expression of tumor necrosis factor alpha (TNF-alpha), interleukin 1-beta (IL-1 beta), and the procoagulant protein tissue factor induced by LPS ex vivo in whole human blood. The addition of a 1-ng/ml bolus of LPS to blood rapidly induced mRNA expression of all three genes. The mRNA levels peaked after 1 to 2 h, depending on the gene, and then declined to baseline after approximately 5 h. The decline in mRNA expression was not caused by a loss of responsiveness of the blood cells to LPS but rather correlated with the neutralization of LPS inflammatory activity by plasma components. Furthermore, administering a 1-ng/ml dose of LPS in six hourly aliquots of 167 pg/ml greatly prolonged the expression of mRNAs and induced a much greater release of TNF-alpha and IL-1 beta protein than did a single bolus. Dosing by repeated additions was more effective than a single bolus in inducing secretion of TNF-alpha and IL-1 beta at LPS levels of < or = 10 ng/ml, which corresponded to the LPS neutralization capacity of plasma. Finally, both mRNA expression and protein secretion induced by repeated administration of LPS were rapidly reversed by the addition of the LPS-neutralizing protein, bactericidal/permeability-increasing protein, even after several hours of stimulation. These results indicate that continuous or repeated exposure to LPS is required to maintain the expression of inflammatory genes and that the activated state is rapidly reversed with LPS neutralization.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7890395      PMCID: PMC173159          DOI: 10.1128/iai.63.4.1362-1368.1995

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  47 in total

1.  Time course of various inflammatory mediators during recurrent endotoxemia.

Authors:  B Klosterhalfen; K Hörstmann-Jungemann; P Vogel; S Flohé; F Offner; C J Kirkpatrick; P C Heinrich
Journal:  Biochem Pharmacol       Date:  1992-05-28       Impact factor: 5.858

2.  Purification and characterization of a potent bactericidal and membrane active protein from the granules of human polymorphonuclear leukocytes.

Authors:  J Weiss; P Elsbach; I Olsson; H Odeberg
Journal:  J Biol Chem       Date:  1978-04-25       Impact factor: 5.157

3.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

Review 4.  Antiendotoxin approaches to septic shock therapy.

Authors:  A L Van Dervort; R L Danner
Journal:  Crit Care Med       Date:  1994-04       Impact factor: 7.598

5.  Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin.

Authors:  D Pennica; G E Nedwin; J S Hayflick; P H Seeburg; R Derynck; M A Palladino; W J Kohr; B B Aggarwal; D V Goeddel
Journal:  Nature       Date:  1984 Dec 20-1985 Jan 2       Impact factor: 49.962

6.  The clearance, tissue distribution, and cellular localization of intravenously injected lipopolysaccharide in rabbits.

Authors:  J C Mathison; R J Ulevitch
Journal:  J Immunol       Date:  1979-11       Impact factor: 5.422

7.  The modification of biophysical and endotoxic properties of bacterial lipopolysaccharides by serum.

Authors:  R J Ulevitch; A R Johnston
Journal:  J Clin Invest       Date:  1978-12       Impact factor: 14.808

8.  Recombinant amino terminal fragment of bactericidal/permeability-increasing protein prevents hemodynamic responses to endotoxin.

Authors:  W S Ammons; A H Kung
Journal:  Circ Shock       Date:  1993-11

9.  Competition between rBPI23, a recombinant fragment of bactericidal/permeability-increasing protein, and lipopolysaccharide (LPS)-binding protein for binding to LPS and gram-negative bacteria.

Authors:  H Gazzano-Santoro; K Mészáros; C Birr; S F Carroll; G Theofan; A H Horwitz; E Lim; S Aberle; H Kasler; J B Parent
Journal:  Infect Immun       Date:  1994-04       Impact factor: 3.441

10.  A recombinant amino terminal fragment of bactericidal/permeability-increasing protein inhibits the induction of leukocyte responses by LPS.

Authors:  K Mészáros; J B Parent; H Gazzano-Santoro; R Little; A Horwitz; T Parsons; G Theofan; L Grinna; J Weickmann; P Elsbach
Journal:  J Leukoc Biol       Date:  1993-12       Impact factor: 4.962

View more
  10 in total

1.  Delayed addition of glucocorticoids selectively suppresses cytokine production in stimulated human whole blood.

Authors:  Devin L Horton; Daniel G Remick
Journal:  Clin Vaccine Immunol       Date:  2010-05-05

2.  Tissue-engineered model for real-time monitoring of liver inflammation.

Authors:  Rohit Jindal; Suraj J Patel; Martin L Yarmush
Journal:  Tissue Eng Part C Methods       Date:  2010-09-28       Impact factor: 3.056

3.  Plasma CD14 decreases monocyte responses to LPS by transferring cell-bound LPS to plasma lipoproteins.

Authors:  R L Kitchens; P A Thompson; S Viriyakosol; G E O'Keefe; R S Munford
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

4.  Potent CD14-mediated signalling of human leukocytes by Escherichia coli can be mediated by interaction of whole bacteria and host cells without extensive prior release of endotoxin.

Authors:  S S Katz; K Chen; S Chen; M E Doerfler; P Elsbach; J Weiss
Journal:  Infect Immun       Date:  1996-09       Impact factor: 3.441

5.  Deacylation of purified lipopolysaccharides by cellular and extracellular components of a sterile rabbit peritoneal inflammatory exudate.

Authors:  Y Weinrauch; S S Katz; R S Munford; P Elsbach; J Weiss
Journal:  Infect Immun       Date:  1999-07       Impact factor: 3.441

6.  Aberrant TNF secretion by whole blood in healthy subjects with a history of reactive arthritis: time course in adherent and non-adherent cultures.

Authors:  K Anttonen; A Orpana; M Leirisalo-Repo; H Repo
Journal:  Ann Rheum Dis       Date:  2005-08-17       Impact factor: 19.103

Review 7.  Microorganisms: crucial players of smokeless tobacco for several health attributes.

Authors:  Akanksha Vishwakarma; Digvijay Verma
Journal:  Appl Microbiol Biotechnol       Date:  2021-07-31       Impact factor: 4.813

8.  Evaluation of a modified method of extraction, purification, and characterization of lipopolysaccharide (O antigen) from Salmonella Typhimurium.

Authors:  Heba M Hassan; Mai A Fadel; Mohamed A Soliman
Journal:  Vet World       Date:  2020-11-05

9.  Chronic TLR Stimulation Controls NLRP3 Inflammasome Activation through IL-10 Mediated Regulation of NLRP3 Expression and Caspase-8 Activation.

Authors:  Prajwal Gurung; Bofeng Li; R K Subbarao Malireddi; Mohamed Lamkanfi; Terrence L Geiger; Thirumala-Devi Kanneganti
Journal:  Sci Rep       Date:  2015-09-28       Impact factor: 4.379

10.  FDXR is a biomarker of radiation exposure in vivo.

Authors:  Gráinne O'Brien; Lourdes Cruz-Garcia; Matthäus Majewski; Jakub Grepl; Michael Abend; Matthias Port; Aleš Tichý; Igor Sirak; Andrea Malkova; Ellen Donovan; Lone Gothard; Sue Boyle; Navita Somaiah; Elizabeth Ainsbury; Lucyna Ponge; Krzysztof Slosarek; Leszek Miszczyk; Piotr Widlak; Edward Green; Neel Patel; Mahesh Kudari; Fergus Gleeson; Volodymyr Vinnikov; Viktor Starenkiy; Sergii Artiukh; Leonid Vasyliev; Azfar Zaman; Christophe Badie
Journal:  Sci Rep       Date:  2018-01-12       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.